Fredrik Widman, VP Corporate Controller at Intuitive Surgical Inc (NASDAQ:ISRG), filed a Form 4 on November 2, 2026, reporting the exercise of 14 non-qualified stock option tranches and the sale of 5,448 shares of common stock on October 30, 2026, all conducted under a Rule 10b5-1 trading plan.

Key Highlights

  • Role: Fredrik Widman is identified in the filing as VP Corporate Controller of Intuitive Surgical Inc.
  • Options exercised: 14 separate non-qualified stock option tranches were exercised on October 30, 2026, collectively covering 5,448 shares acquired at exercise prices ranging from $79.6378 to $347.4167.
  • Shares sold: 5,448 shares of common stock were disposed of on October 30, 2026, at a weighted average sale price of $436.0551, with individual transaction prices ranging from $431.64 to $453.60.
  • Post-transaction ownership: Following all reported transactions, Widman directly and beneficially owned 1,026 shares of common stock.
  • 10b5-1 plan: According to the filing, "The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 15, 2027."
  • Remaining derivative securities: Multiple non-qualified stock options remain outstanding after the exercise transactions, with expiration dates ranging from February 15, 2027 through August 26, 2031.

Widman's October 30 Option Exercises and Share Sale at Intuitive Surgical

According to the Form 4 filed with the SEC on November 2, 2026, Fredrik Widman, VP Corporate Controller, executed a series of transactions on October 30, 2026, under a pre-established Rule 10b5-1 trading plan. The filing reports 14 separate option exercise transactions (transaction code "M"), each converting non-qualified stock options into shares of common stock at exercise prices spanning from $79.6378 to $347.4167 per share. The acquired shares were reported under Table I as acquired at those respective exercise prices, progressively increasing Widman's directly held share count from 1,026 shares (at the start of the sequence) up to 6,474 shares before the subsequent sale.

The filing then reports a single sale transaction (transaction code "S") of 5,448 shares at a weighted average price of $436.0551. The sale was executed in multiple sub-transactions at prices ranging from $431.64 to $453.60. The largest sub-tranche consisted of 2,650 shares sold at prices between $431.64 and $432.57. After all transactions settled, Widman's directly held beneficial ownership stood at 1,026 shares of common stock, according to the filing.

In Table II, the filing lists 14 non-qualified stock option positions remaining following the exercise transactions, with the same share counts as those exercised still shown as beneficially owned (in some cases reflecting partial remaining balances). Options carry expiration dates between February 15, 2027, and August 26, 2031, and were granted under Intuitive Surgical's 2010 Incentive Award Plan, with various vesting schedules as described in the filing's footnotes. All transactions were attributed to Widman's 10b5-1 plan, which the filing states expires on September 15, 2027. The form was signed by Stephanie Lim-Ignacio on behalf of Widman on November 2, 2026.

What Was Disclosed

Intuitive Surgical's VP Corporate Controller Fredrik Widman reported the exercise of 14 non-qualified stock option tranches and the sale of 5,448 shares on October 30, 2026, under a Rule 10b5-1 plan, leaving him with 1,026 directly owned shares.